Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

NCT07583992 is registered in ClinicalTrials.gov with National Research Institute of Chinese Medicine, Ministry of Health and Welfare as lead sponsor.

NCT NCT07583992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07583992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia
Lead sponsor
National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
November 30, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic therapy, community-acquired pneumonia (cap), hospitalisation, intravenous, mild to moderate